Lloyd, J.O.
Hill, B.
Murphy, M.
Al-Kaisy, A.
Andreou, A. P.
Lambru, G. https://orcid.org/0000-0002-2780-4776
Article History
Received: 14 January 2022
Accepted: 2 May 2022
First Online: 6 June 2022
Declarations
:
: Audit under current national guidelines does not require prior research ethics committee review (http:///).
: Not applicable.
: JL reports no disclosure. B.H. reports no disclosure. M.M. reports no disclosure. AAK investigator with Nevro, Boston Scientific, Abbott and Medtronic and has stock in Micron LLC. A.P.A received speaker honoraria and funding for travel from Allergan, Eli Lilly and eNeura, honoraria for participation in advisory boards sponsored by Allergan and Eli Lilly, sponsorship for educational purposes from eNeura, Allergan, Autonomic Technologies and Novartis, and an equipment grant from eNeura. G.L. has received speaker honoraria, funding for travel and has received honoraria for participation in advisory boards sponsored by Allergan, Novartis, Eli Lilly, TEVA and Lundbeck. He has received speaker honoraria, funding for travel from electroCore, Nevro Corp. and Autonomic Technologies.